Indian drugmaker Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical Industries is acquiring Organon & Co for $11.75 billion in an all-cash deal, which will elevate its revenue to $12.4 billion and position it among the top 25 global pharmaceutical companies. Organon, a U.S. firm specializing in women's health and biosimilars, was spun off from Merck in 2021.
Topics: acquisition global market expansion Organon & Co pharmaceutical industry Sun Pharmaceutical Industries